US and Europe Gene Editing Market Forecast to 2030 - Country Analysis by Technology [CRISPR, TALEN, Antisense, Zinc Finger Nucleases (ZFNs), and Others], Product and Service (Reagents and Consumables, Instruments, and Others), Application (Cell Line Engineering, Genetic Engineering, Diagnostic Applications, Drug Discovery, and Others), and End User (Pharmaceutical & Biotechnology Companies, Academic and Research Institutes, Clinical Research Organizations, and Others)
The US & EU gene editing market is projected to reach US$ 15,052.92 million by 2030 from US$ 3,955.09 million in 2022; it is expected to grow at a CAGR of 18.2% from 2022 to 2030.
The factors such as rise in the prevalence of cancer and other genetic disorders and continuous technological advancements in gene editing tools are expected to drive the US & EU gene editing market growth. Moreover, growing innovations and rising investments in biotechnology is also expected to foster the US & EU gene editing market growth during the forecast period. However, the high cost of production of gene editing methods may hinder the US & EU gene editing market growth.
Strategic Initiatives by Market Players to Develop New Products to Boost the US & EU Gene Editing Market in Future
Technological developments in healthcare IT allow the use of artificial intelligence (AI) for manufacturing CRISPR Systems. Developers working in the healthcare IT domain are engaged in analyzing the processes to control and monitor all the stages of product development. The focus is to develop technologies from discovering biomarkers to clinical trials and patient monitoring. A few companies have initiated implementing their expertise to use AI for digital manufacturing. In February 2023, Sherlock Biosciences, which develops CRISPR, synthetic biology, and artificial intelligence (AI) technologies, acquired Sense Biodetection, an Oxford, UK-based developer of a rapid molecular testing platform. This acquisition accelerates Sherlock's ability to put the most advanced CRISPR-based diagnostics conveniently in the hands of global consumers.
In January 2020, ERS Genomics and New England Biolab collaborated to develop and commercialize CRISPR gene modification tools and reagents. New England Biolab offers the largest selection of recombinant and native enzymes for genomic research. The company continues expanding its product offerings into new research areas, including genome editing. As a provider of CRISPR/Cas9 reagents and tools, NEB's license from ERS Genomics expands the company's rights to use and sell these technologies.
Thus, such initiatives are expected to foster genome editing and enhance the US & EU gene editing market growth in the coming years.
The US & EU gene editing market is segmented on the basis of technology, product and services, application, and end user. Based on the technology is segmented into CRISPR, TALEN, antisense, Zinc Finger Nucleases (ZFNs), and others. In 2022, the CRISPR segment held the largest share of the US & EU gene editing market. Moreover, the same segment is also expected to grow at the fastest rate during the coming years. Based on the products and services is segmented into reagents and consumables, instruments, and others. In 2022, the reagents and consumables segment held the largest share of the US & EU gene editing market. Moreover, the same segment is also expected to grow at the fastest rate during the coming years. Based on the application is segmented into cell line engineering, genetic engineering, diagnostic application, drug discovery, and others. In 2022, the cell line engineering segment held the largest share of the market. Moreover, the same segment is also expected to grow at the fastest rate during the coming years. Based on the end user is segmented into pharmaceutical & biotechnology companies, academic and research institutes, contract research organization (CROs), others. In 2022, the pharmaceutical & biotechnology companies segment held the largest share of the US & EU gene editing market. However, the academic and research institutes segment is expected to grow at the fastest rate during the coming years.
The World Health Organization (WHO), Centre For Research in Agricultural Genomics (CRAG), Centers for Disease Control and Prevention (CDC), Department For Environment, Food, And Rural Affairs (DEFRA), Food And Agricultural Organization (FAO), US Food and Drug Administration (FDA), Italian Society of Agricultural Genetics (SIGA) are among some of the primary and secondary sources referred to while preparing the report on the US & EU gene editing market.
The factors such as rise in the prevalence of cancer and other genetic disorders and continuous technological advancements in gene editing tools are expected to drive the US & EU gene editing market growth. Moreover, growing innovations and rising investments in biotechnology is also expected to foster the US & EU gene editing market growth during the forecast period. However, the high cost of production of gene editing methods may hinder the US & EU gene editing market growth.
Strategic Initiatives by Market Players to Develop New Products to Boost the US & EU Gene Editing Market in Future
Technological developments in healthcare IT allow the use of artificial intelligence (AI) for manufacturing CRISPR Systems. Developers working in the healthcare IT domain are engaged in analyzing the processes to control and monitor all the stages of product development. The focus is to develop technologies from discovering biomarkers to clinical trials and patient monitoring. A few companies have initiated implementing their expertise to use AI for digital manufacturing. In February 2023, Sherlock Biosciences, which develops CRISPR, synthetic biology, and artificial intelligence (AI) technologies, acquired Sense Biodetection, an Oxford, UK-based developer of a rapid molecular testing platform. This acquisition accelerates Sherlock's ability to put the most advanced CRISPR-based diagnostics conveniently in the hands of global consumers.
In January 2020, ERS Genomics and New England Biolab collaborated to develop and commercialize CRISPR gene modification tools and reagents. New England Biolab offers the largest selection of recombinant and native enzymes for genomic research. The company continues expanding its product offerings into new research areas, including genome editing. As a provider of CRISPR/Cas9 reagents and tools, NEB's license from ERS Genomics expands the company's rights to use and sell these technologies.
Thus, such initiatives are expected to foster genome editing and enhance the US & EU gene editing market growth in the coming years.
The US & EU gene editing market is segmented on the basis of technology, product and services, application, and end user. Based on the technology is segmented into CRISPR, TALEN, antisense, Zinc Finger Nucleases (ZFNs), and others. In 2022, the CRISPR segment held the largest share of the US & EU gene editing market. Moreover, the same segment is also expected to grow at the fastest rate during the coming years. Based on the products and services is segmented into reagents and consumables, instruments, and others. In 2022, the reagents and consumables segment held the largest share of the US & EU gene editing market. Moreover, the same segment is also expected to grow at the fastest rate during the coming years. Based on the application is segmented into cell line engineering, genetic engineering, diagnostic application, drug discovery, and others. In 2022, the cell line engineering segment held the largest share of the market. Moreover, the same segment is also expected to grow at the fastest rate during the coming years. Based on the end user is segmented into pharmaceutical & biotechnology companies, academic and research institutes, contract research organization (CROs), others. In 2022, the pharmaceutical & biotechnology companies segment held the largest share of the US & EU gene editing market. However, the academic and research institutes segment is expected to grow at the fastest rate during the coming years.
The World Health Organization (WHO), Centre For Research in Agricultural Genomics (CRAG), Centers for Disease Control and Prevention (CDC), Department For Environment, Food, And Rural Affairs (DEFRA), Food And Agricultural Organization (FAO), US Food and Drug Administration (FDA), Italian Society of Agricultural Genetics (SIGA) are among some of the primary and secondary sources referred to while preparing the report on the US & EU gene editing market.
1. INTRODUCTION
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 US and Europe Gene Editing Market– By Technology
1.3.2 US and Europe Gene Editing Market– By Products and Services
1.3.3 US and Europe Gene Editing Market– By Application
1.3.4 US and Europe Gene Editing Market– By End User
1.3.5 Gene Editing Market– By Geography
2. EXECUTIVE SUMMARY
3. RESEARCH METHODOLOGY
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. US AND EUROPE GENE EDITING MARKET – MARKET LANDSCAPE
4.1 Overview
4.2 PEST Analysis
4.2.1 US – PEST Analysis
4.2.2 Europe – PEST Analysis
4.3 Expert Opinions
5. GENE EDITING MARKET – KEY MARKET DYNAMICS
5.1 Market Drivers
5.1.1 Rise in Prevalence of Cancer and Other Genetic Disorders
5.1.2 Continuous Technological Advancements in Gene Editing Tools
5.2 Market Restraints
5.2.1 High Cost of Production of Gene Editing Methods
5.3 Market Opportunities
5.3.1 Growing Biotechnology Industry in US and Europe
5.4 Future Trends
5.4.1 Strategic Initiatives by Market Players to Develop New Products
5.5 Impact Analysis
6. GENE EDITING MARKET – US AND EUROPE ANALYSIS
6.1 US and Europe Gene Editing Market Revenue Forecast and Analysis
6.2 Market Positioning of Key Players
7. US AND EUROPE GENE EDITING MARKET ANALYSIS – BY TECHNOLOGY
7.1 Overview
7.1.1 US and Europe Gene Editing Market, By Technology 2022 & 2030 (%)
7.2 CRISPR
7.2.1 Overview
7.2.2 US and Europe CRISPR Market Revenue and Forecasts to 2030 (US$ Million)
7.3 TALEN
7.3.1 Overview
7.3.2 US and Europe TALEN Market Revenue and Forecasts to 2030 (US$ Million)
7.4 Antisense
7.4.1 Overview
7.4.2 US and Europe Antisense Market Revenue and Forecasts to 2030 (US$ Million)
7.5 Zinc Finger Nucleases (ZFNs)
7.5.1 Overview
7.5.2 US and Europe Zinc Finger Nucleases (ZFNs)Market Revenue and Forecasts to 2030 (US$ Million)
7.6 Others
7.6.1 Overview
7.6.2 US and Europe Others Market Revenue and Forecasts to 2030 (US$ Million)
8. US AND EUROPE GENE EDITING MARKET ANALYSIS – BY PRODUCTS AND SERVICES
8.1 Overview
8.1.1 US and Europe Gene Editing Market, By Products and Services 2022 & 2030 (%)
8.2 Reagents and Consumables
8.2.1 Overview
8.2.2 US and Europe Reagents and Consumables Market Revenue and Forecasts to 2030 (US$ Million)
8.3 Instruments
8.3.1 Overview
8.3.2 US and Europe Instruments Market Revenue and Forecasts to 2030 (US$ Million)
8.4 Others
8.4.1 Overview
8.4.2 US and Europe Others Market Revenue and Forecasts to 2030 (US$ Million)
9. US AND EUROPE GENE EDITING MARKET ANALYSIS – BY APPLICATION
9.1 Overview
9.1.1 US and Europe Gene Editing Market, By Application 2022 & 2030 (%)
9.2 Cell Line Engineering
9.2.1 Overview
9.2.2 US and Europe Cell Line Engineering Market Revenue and Forecasts to 2030 (US$ Million)
9.3 Genetic Engineering
9.3.1 Overview
9.3.2 US and Europe Genetic Engineering Market Revenue and Forecasts to 2030 (US$ Million)
9.4 Diagnostic Application
9.4.1 Overview
9.4.2 US and Europe Diagnostic Application Market Revenue and Forecasts to 2030 (US$ Million)
9.5 Drug Discovery
9.5.1 Overview
9.5.2 US and Europe Drug Discovery Market Revenue and Forecasts to 2030 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 US and Europe Others Market Revenue and Forecasts to 2030 (US$ Million)
10. US AND EUROPE GENE EDITING MARKET ANALYSIS – BY END USER
10.1 Overview
10.1.1 US and Europe Gene Editing Market, By End User 2022 & 2030 (%)
10.2 Pharmaceutical & Biotechnology Companies
10.2.1 Overview
10.2.2 US and Europe Pharmaceutical & Biotechnology Companies Market Revenue and Forecasts to 2030 (US$ Million)
10.3 Academic and Research Institutes
10.3.1 Overview
10.3.2 US and Europe Academic and Research Institutes Market Revenue and Forecasts to 2030 (US$ Million)
10.4 Contract Research Organization (CROs)
10.4.1 Overview
10.4.2 US and Europe Contract Research Organization (CROs) Market Revenue and Forecasts to 2030 (US$ Million)
10.5 Others
10.5.1 Overview
10.5.2 US and Europe Others Market Revenue and Forecasts to 2030 (US$ Million)
11. US AND EUROPE GENE EDITING MARKET ANALYSIS
11.1 US Gene Editing Market Revenue Forecast and Analysis
11.1.1 Overview
11.1.2 US: Gene Editing Market - Revenue and Forecasts to 2030 (USD Million)
11.1.3 US: Gene Editing Market- Revenue and Forecasts to 2030, By Technology (USD Million)
11.1.4 US: Gene Editing Market- Revenue and Forecasts to 2030, By Products and Services (USD Million)
11.1.5 US: Gene Editing Market- Revenue and Forecasts to 2030, By Application (USD Million)
11.1.6 US: Gene Editing Market- Revenue and Forecasts to 2030, By End User (USD Million)
11.2 Europe Gene Editing Market Revenue Forecast and Analysis
11.2.1 Overview
11.2.2 Europe: Gene Editing Market - Revenue and Forecasts to 2030 (USD Million)
11.2.3 Europe: Gene Editing Market- Revenue and Forecasts to 2030, By Technology (USD Million)
11.2.4 Europe: Gene Editing Market- Revenue and Forecasts to 2030, By Products and Services (USD Million)
11.2.5 Europe: Gene Editing Market- Revenue and Forecasts to 2030, By Application (USD Million)
11.2.6 Europe: Gene Editing Market- Revenue and Forecasts to 2030, By End User (USD Million)
11.2.7 Europe: Gene Editing Market- Revenue and Forecasts to 2030, By Country (%)
11.2.8 Germany: Gene Editing Market – Revenue and Forecast to 2030 (USD Million)
11.2.8.1 Germany: Gene Editing Market – Revenue and Forecast to 2030 (USD Million)
11.2.8.2 Germany: Gene Editing Market- Revenue and Forecasts to 2030, By Technology (USD Million)
11.2.8.3 Germany: Gene Editing Market- Revenue and Forecasts to 2030, By Products and Services (USD Million)
11.2.8.4 Germany: Gene Editing Market- Revenue and Forecasts to 2030, By Application (USD Million)
11.2.8.5 Germany: Gene Editing Market- Revenue and Forecasts to 2030, By End User (USD Million)
11.2.9 UK: Gene Editing Market – Revenue and Forecast to 2030 (USD Million)
11.2.9.1 UK: Gene Editing Market – Revenue and Forecast to 2030 (USD Million)
11.2.9.2 UK: Gene Editing Market- Revenue and Forecasts to 2030, By Technology (USD Million)
11.2.9.3 UK: Gene Editing Market- Revenue and Forecasts to 2030, By Products and Services (USD Million)
11.2.9.4 UK: Gene Editing Market- Revenue and Forecasts to 2030, By Application (USD Million)
11.2.9.5 UK: Gene Editing Market- Revenue and Forecasts to 2030, By End User (USD Million)
11.2.10 France: Gene Editing Market – Revenue and Forecast to 2030 (USD Million)
11.2.10.1 France: Gene Editing Market – Revenue and Forecast to 2030 (USD Million)
11.2.10.2 France: Gene Editing Market- Revenue and Forecasts to 2030, By Technology (USD Million)
11.2.10.3 France: Gene Editing Market- Revenue and Forecasts to 2030, By Products and Services (USD Million)
11.2.10.4 France: Gene Editing Market- Revenue and Forecasts to 2030, By Application (USD Million)
11.2.10.5 France: Gene Editing Market- Revenue and Forecasts to 2030, By End User (USD Million)
11.2.11 Italy: Gene Editing Market – Revenue and Forecast to 2030 (USD Million)
11.2.11.1 Italy: Gene Editing Market – Revenue and Forecast to 2030 (USD Million)
11.2.11.2 Italy: Gene Editing Market- Revenue and Forecasts to 2030, By Technology (USD Million)
11.2.11.3 Italy: Gene Editing Market- Revenue and Forecasts to 2030, By Products and Services (USD Million)
11.2.11.4 Italy: Gene Editing Market- Revenue and Forecasts to 2030, By Application (USD Million)
11.2.11.5 Italy: Gene Editing Market- Revenue and Forecasts to 2030, By End User (USD Million)
11.2.12 Spain: Gene Editing Market – Revenue and Forecast to 2030 (USD Million)
11.2.12.1 Spain: Gene Editing Market – Revenue and Forecast to 2030 (USD Million)
11.2.12.2 Spain: Gene Editing Market- Revenue and Forecasts to 2030, By Technology (USD Million)
11.2.12.3 Spain: Gene Editing Market- Revenue and Forecasts to 2030, By Products and Services (USD Million)
11.2.12.4 Spain: Gene Editing Market- Revenue and Forecasts to 2030, By Application (USD Million)
11.2.12.5 Spain: Gene Editing Market- Revenue and Forecasts to 2030, By End User (USD Million)
11.2.13 Rest of Europe: Gene Editing Market – Revenue and Forecast to 2030 (USD Million)
11.2.13.1 Rest of Europe: Gene Editing Market – Revenue and Forecast to 2030 (USD Million)
11.2.13.2 Rest of Europe: Gene Editing Market- Revenue and Forecasts to 2030, By Technology (USD Million)
11.2.13.3 Rest of Europe: Gene Editing Market- Revenue and Forecasts to 2030, By Products and Services (USD Million)
11.2.13.4 Rest of Europe: Gene Editing Market- Revenue and Forecasts to 2030, By Application (USD Million)
11.2.13.5 Rest of Europe: Gene Editing Market- Revenue and Forecasts to 2030, By End User (USD Million)
12. INDUSTRY LANDSCAPE
12.1 Overview
12.2 Growth Strategies in US and Europe Gene Editing Market
12.3 Organic Growth Strategies
12.3.1 Overview
12.4 Inorganic Growth Strategies
12.4.1 Overview
13. COMPANY PROFILES
13.1 Thermo Fisher Scientific Inc
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Merck KGaA
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Lonza Group AG
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Horizon Discovery Group plc.
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Integrated DNA Technologies, Inc.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 GenScript Biotech Corporation
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 New England Biolabs
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Eurofins Scientific SE
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 CRISPR Therapeutics
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Editas Medicine Inc
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
13.11 ElevateBio LLC
13.11.1 Key Facts
13.11.2 Business Description
13.11.3 Products and Services
13.11.4 Financial Overview
13.11.5 SWOT Analysis
13.11.6 Key Developments
14. APPENDIX
14.1 Glossary of Terms
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 US and Europe Gene Editing Market– By Technology
1.3.2 US and Europe Gene Editing Market– By Products and Services
1.3.3 US and Europe Gene Editing Market– By Application
1.3.4 US and Europe Gene Editing Market– By End User
1.3.5 Gene Editing Market– By Geography
2. EXECUTIVE SUMMARY
3. RESEARCH METHODOLOGY
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. US AND EUROPE GENE EDITING MARKET – MARKET LANDSCAPE
4.1 Overview
4.2 PEST Analysis
4.2.1 US – PEST Analysis
4.2.2 Europe – PEST Analysis
4.3 Expert Opinions
5. GENE EDITING MARKET – KEY MARKET DYNAMICS
5.1 Market Drivers
5.1.1 Rise in Prevalence of Cancer and Other Genetic Disorders
5.1.2 Continuous Technological Advancements in Gene Editing Tools
5.2 Market Restraints
5.2.1 High Cost of Production of Gene Editing Methods
5.3 Market Opportunities
5.3.1 Growing Biotechnology Industry in US and Europe
5.4 Future Trends
5.4.1 Strategic Initiatives by Market Players to Develop New Products
5.5 Impact Analysis
6. GENE EDITING MARKET – US AND EUROPE ANALYSIS
6.1 US and Europe Gene Editing Market Revenue Forecast and Analysis
6.2 Market Positioning of Key Players
7. US AND EUROPE GENE EDITING MARKET ANALYSIS – BY TECHNOLOGY
7.1 Overview
7.1.1 US and Europe Gene Editing Market, By Technology 2022 & 2030 (%)
7.2 CRISPR
7.2.1 Overview
7.2.2 US and Europe CRISPR Market Revenue and Forecasts to 2030 (US$ Million)
7.3 TALEN
7.3.1 Overview
7.3.2 US and Europe TALEN Market Revenue and Forecasts to 2030 (US$ Million)
7.4 Antisense
7.4.1 Overview
7.4.2 US and Europe Antisense Market Revenue and Forecasts to 2030 (US$ Million)
7.5 Zinc Finger Nucleases (ZFNs)
7.5.1 Overview
7.5.2 US and Europe Zinc Finger Nucleases (ZFNs)Market Revenue and Forecasts to 2030 (US$ Million)
7.6 Others
7.6.1 Overview
7.6.2 US and Europe Others Market Revenue and Forecasts to 2030 (US$ Million)
8. US AND EUROPE GENE EDITING MARKET ANALYSIS – BY PRODUCTS AND SERVICES
8.1 Overview
8.1.1 US and Europe Gene Editing Market, By Products and Services 2022 & 2030 (%)
8.2 Reagents and Consumables
8.2.1 Overview
8.2.2 US and Europe Reagents and Consumables Market Revenue and Forecasts to 2030 (US$ Million)
8.3 Instruments
8.3.1 Overview
8.3.2 US and Europe Instruments Market Revenue and Forecasts to 2030 (US$ Million)
8.4 Others
8.4.1 Overview
8.4.2 US and Europe Others Market Revenue and Forecasts to 2030 (US$ Million)
9. US AND EUROPE GENE EDITING MARKET ANALYSIS – BY APPLICATION
9.1 Overview
9.1.1 US and Europe Gene Editing Market, By Application 2022 & 2030 (%)
9.2 Cell Line Engineering
9.2.1 Overview
9.2.2 US and Europe Cell Line Engineering Market Revenue and Forecasts to 2030 (US$ Million)
9.3 Genetic Engineering
9.3.1 Overview
9.3.2 US and Europe Genetic Engineering Market Revenue and Forecasts to 2030 (US$ Million)
9.4 Diagnostic Application
9.4.1 Overview
9.4.2 US and Europe Diagnostic Application Market Revenue and Forecasts to 2030 (US$ Million)
9.5 Drug Discovery
9.5.1 Overview
9.5.2 US and Europe Drug Discovery Market Revenue and Forecasts to 2030 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 US and Europe Others Market Revenue and Forecasts to 2030 (US$ Million)
10. US AND EUROPE GENE EDITING MARKET ANALYSIS – BY END USER
10.1 Overview
10.1.1 US and Europe Gene Editing Market, By End User 2022 & 2030 (%)
10.2 Pharmaceutical & Biotechnology Companies
10.2.1 Overview
10.2.2 US and Europe Pharmaceutical & Biotechnology Companies Market Revenue and Forecasts to 2030 (US$ Million)
10.3 Academic and Research Institutes
10.3.1 Overview
10.3.2 US and Europe Academic and Research Institutes Market Revenue and Forecasts to 2030 (US$ Million)
10.4 Contract Research Organization (CROs)
10.4.1 Overview
10.4.2 US and Europe Contract Research Organization (CROs) Market Revenue and Forecasts to 2030 (US$ Million)
10.5 Others
10.5.1 Overview
10.5.2 US and Europe Others Market Revenue and Forecasts to 2030 (US$ Million)
11. US AND EUROPE GENE EDITING MARKET ANALYSIS
11.1 US Gene Editing Market Revenue Forecast and Analysis
11.1.1 Overview
11.1.2 US: Gene Editing Market - Revenue and Forecasts to 2030 (USD Million)
11.1.3 US: Gene Editing Market- Revenue and Forecasts to 2030, By Technology (USD Million)
11.1.4 US: Gene Editing Market- Revenue and Forecasts to 2030, By Products and Services (USD Million)
11.1.5 US: Gene Editing Market- Revenue and Forecasts to 2030, By Application (USD Million)
11.1.6 US: Gene Editing Market- Revenue and Forecasts to 2030, By End User (USD Million)
11.2 Europe Gene Editing Market Revenue Forecast and Analysis
11.2.1 Overview
11.2.2 Europe: Gene Editing Market - Revenue and Forecasts to 2030 (USD Million)
11.2.3 Europe: Gene Editing Market- Revenue and Forecasts to 2030, By Technology (USD Million)
11.2.4 Europe: Gene Editing Market- Revenue and Forecasts to 2030, By Products and Services (USD Million)
11.2.5 Europe: Gene Editing Market- Revenue and Forecasts to 2030, By Application (USD Million)
11.2.6 Europe: Gene Editing Market- Revenue and Forecasts to 2030, By End User (USD Million)
11.2.7 Europe: Gene Editing Market- Revenue and Forecasts to 2030, By Country (%)
11.2.8 Germany: Gene Editing Market – Revenue and Forecast to 2030 (USD Million)
11.2.8.1 Germany: Gene Editing Market – Revenue and Forecast to 2030 (USD Million)
11.2.8.2 Germany: Gene Editing Market- Revenue and Forecasts to 2030, By Technology (USD Million)
11.2.8.3 Germany: Gene Editing Market- Revenue and Forecasts to 2030, By Products and Services (USD Million)
11.2.8.4 Germany: Gene Editing Market- Revenue and Forecasts to 2030, By Application (USD Million)
11.2.8.5 Germany: Gene Editing Market- Revenue and Forecasts to 2030, By End User (USD Million)
11.2.9 UK: Gene Editing Market – Revenue and Forecast to 2030 (USD Million)
11.2.9.1 UK: Gene Editing Market – Revenue and Forecast to 2030 (USD Million)
11.2.9.2 UK: Gene Editing Market- Revenue and Forecasts to 2030, By Technology (USD Million)
11.2.9.3 UK: Gene Editing Market- Revenue and Forecasts to 2030, By Products and Services (USD Million)
11.2.9.4 UK: Gene Editing Market- Revenue and Forecasts to 2030, By Application (USD Million)
11.2.9.5 UK: Gene Editing Market- Revenue and Forecasts to 2030, By End User (USD Million)
11.2.10 France: Gene Editing Market – Revenue and Forecast to 2030 (USD Million)
11.2.10.1 France: Gene Editing Market – Revenue and Forecast to 2030 (USD Million)
11.2.10.2 France: Gene Editing Market- Revenue and Forecasts to 2030, By Technology (USD Million)
11.2.10.3 France: Gene Editing Market- Revenue and Forecasts to 2030, By Products and Services (USD Million)
11.2.10.4 France: Gene Editing Market- Revenue and Forecasts to 2030, By Application (USD Million)
11.2.10.5 France: Gene Editing Market- Revenue and Forecasts to 2030, By End User (USD Million)
11.2.11 Italy: Gene Editing Market – Revenue and Forecast to 2030 (USD Million)
11.2.11.1 Italy: Gene Editing Market – Revenue and Forecast to 2030 (USD Million)
11.2.11.2 Italy: Gene Editing Market- Revenue and Forecasts to 2030, By Technology (USD Million)
11.2.11.3 Italy: Gene Editing Market- Revenue and Forecasts to 2030, By Products and Services (USD Million)
11.2.11.4 Italy: Gene Editing Market- Revenue and Forecasts to 2030, By Application (USD Million)
11.2.11.5 Italy: Gene Editing Market- Revenue and Forecasts to 2030, By End User (USD Million)
11.2.12 Spain: Gene Editing Market – Revenue and Forecast to 2030 (USD Million)
11.2.12.1 Spain: Gene Editing Market – Revenue and Forecast to 2030 (USD Million)
11.2.12.2 Spain: Gene Editing Market- Revenue and Forecasts to 2030, By Technology (USD Million)
11.2.12.3 Spain: Gene Editing Market- Revenue and Forecasts to 2030, By Products and Services (USD Million)
11.2.12.4 Spain: Gene Editing Market- Revenue and Forecasts to 2030, By Application (USD Million)
11.2.12.5 Spain: Gene Editing Market- Revenue and Forecasts to 2030, By End User (USD Million)
11.2.13 Rest of Europe: Gene Editing Market – Revenue and Forecast to 2030 (USD Million)
11.2.13.1 Rest of Europe: Gene Editing Market – Revenue and Forecast to 2030 (USD Million)
11.2.13.2 Rest of Europe: Gene Editing Market- Revenue and Forecasts to 2030, By Technology (USD Million)
11.2.13.3 Rest of Europe: Gene Editing Market- Revenue and Forecasts to 2030, By Products and Services (USD Million)
11.2.13.4 Rest of Europe: Gene Editing Market- Revenue and Forecasts to 2030, By Application (USD Million)
11.2.13.5 Rest of Europe: Gene Editing Market- Revenue and Forecasts to 2030, By End User (USD Million)
12. INDUSTRY LANDSCAPE
12.1 Overview
12.2 Growth Strategies in US and Europe Gene Editing Market
12.3 Organic Growth Strategies
12.3.1 Overview
12.4 Inorganic Growth Strategies
12.4.1 Overview
13. COMPANY PROFILES
13.1 Thermo Fisher Scientific Inc
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Merck KGaA
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Lonza Group AG
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Horizon Discovery Group plc.
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Integrated DNA Technologies, Inc.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 GenScript Biotech Corporation
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 New England Biolabs
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Eurofins Scientific SE
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 CRISPR Therapeutics
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Editas Medicine Inc
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
13.11 ElevateBio LLC
13.11.1 Key Facts
13.11.2 Business Description
13.11.3 Products and Services
13.11.4 Financial Overview
13.11.5 SWOT Analysis
13.11.6 Key Developments
14. APPENDIX
14.1 Glossary of Terms
LIST OF TABLES
Table 1. US: Gene Editing Market, By Technology – Revenue and Forecast to 2030 (USD Million)
Table 2. US: Gene Editing Market, By Products and Services – Revenue and Forecast to 2030 (USD Million)
Table 3. US: Gene Editing Market, By Application– Revenue and Forecast to 2030 (USD Million)
Table 4. US: Gene Editing Market, By End User– Revenue and Forecast to 2030 (USD Million)
Table 5. Europe: Gene Editing Market, By Technology – Revenue and Forecast to 2030 (USD Million)
Table 6. Europe: Gene Editing Market, By Products and Services – Revenue and Forecast to 2030 (USD Million)
Table 7. Europe: Gene Editing Market, By Application– Revenue and Forecast to 2030 (USD Million)
Table 8. Europe: Gene Editing Market, By End User– Revenue and Forecast to 2030 (USD Million)
Table 9. Germany: Gene Editing Market, By Technology – Revenue and Forecast to 2030 (USD Million)
Table 10. Germany: Gene Editing Market, By Products and Services – Revenue and Forecast to 2030 (USD Million)
Table 11. Germany: Gene Editing Market, By Application– Revenue and Forecast to 2030 (USD Million)
Table 12. Germany: Gene Editing Market, By End User– Revenue and Forecast to 2030 (USD Million)
Table 13. UK: Gene Editing Market, By Technology – Revenue and Forecast to 2030 (USD Million)
Table 14. UK: Gene Editing Market, By Products and Services – Revenue and Forecast to 2030 (USD Million)
Table 15. UK: Gene Editing Market, By Application– Revenue and Forecast to 2030 (USD Million)
Table 16. UK: Gene Editing Market, By End User– Revenue and Forecast to 2030 (USD Million)
Table 17. France: Gene Editing Market, By Technology – Revenue and Forecast to 2030 (USD Million)
Table 18. France: Gene Editing Market, By Products and Services – Revenue and Forecast to 2030 (USD Million)
Table 19. France: Gene Editing Market, By Application– Revenue and Forecast to 2030 (USD Million)
Table 20. France: Gene Editing Market, By End User– Revenue and Forecast to 2030 (USD Million)
Table 21. Italy: Gene Editing Market, By Technology – Revenue and Forecast to 2030 (USD Million)
Table 22. Italy: Gene Editing Market, By Products and Services – Revenue and Forecast to 2030 (USD Million)
Table 23. Italy: Gene Editing Market, By Application– Revenue and Forecast to 2030 (USD Million)
Table 24. Italy: Gene Editing Market, By End User– Revenue and Forecast to 2030 (USD Million)
Table 25. Spain: Gene Editing Market, By Technology – Revenue and Forecast to 2030 (USD Million)
Table 26. Spain: Gene Editing Market, By Products and Services – Revenue and Forecast to 2030 (USD Million)
Table 27. Spain: Gene Editing Market, By Application– Revenue and Forecast to 2030 (USD Million)
Table 28. Spain: Gene Editing Market, By End User– Revenue and Forecast to 2030 (USD Million)
Table 29. Rest of Europe: Gene Editing Market, By Technology – Revenue and Forecast to 2030 (USD Million)
Table 30. Rest of Europe: Gene Editing Market, By Products and Services – Revenue and Forecast to 2030 (USD Million)
Table 31. Rest of Europe: Gene Editing Market, By Application– Revenue and Forecast to 2030 (USD Million)
Table 32. Rest of Europe: Gene Editing Market, By End User– Revenue and Forecast to 2030 (USD Million)
Table 33. Recent Organic Growth Strategies in US and Europe Gene Editing Market
Table 34. Recent Inorganic Growth Strategies in the US and Europe Gene Editing Market
Table 35. Glossary of Terms, Gene Editing Market
Table 1. US: Gene Editing Market, By Technology – Revenue and Forecast to 2030 (USD Million)
Table 2. US: Gene Editing Market, By Products and Services – Revenue and Forecast to 2030 (USD Million)
Table 3. US: Gene Editing Market, By Application– Revenue and Forecast to 2030 (USD Million)
Table 4. US: Gene Editing Market, By End User– Revenue and Forecast to 2030 (USD Million)
Table 5. Europe: Gene Editing Market, By Technology – Revenue and Forecast to 2030 (USD Million)
Table 6. Europe: Gene Editing Market, By Products and Services – Revenue and Forecast to 2030 (USD Million)
Table 7. Europe: Gene Editing Market, By Application– Revenue and Forecast to 2030 (USD Million)
Table 8. Europe: Gene Editing Market, By End User– Revenue and Forecast to 2030 (USD Million)
Table 9. Germany: Gene Editing Market, By Technology – Revenue and Forecast to 2030 (USD Million)
Table 10. Germany: Gene Editing Market, By Products and Services – Revenue and Forecast to 2030 (USD Million)
Table 11. Germany: Gene Editing Market, By Application– Revenue and Forecast to 2030 (USD Million)
Table 12. Germany: Gene Editing Market, By End User– Revenue and Forecast to 2030 (USD Million)
Table 13. UK: Gene Editing Market, By Technology – Revenue and Forecast to 2030 (USD Million)
Table 14. UK: Gene Editing Market, By Products and Services – Revenue and Forecast to 2030 (USD Million)
Table 15. UK: Gene Editing Market, By Application– Revenue and Forecast to 2030 (USD Million)
Table 16. UK: Gene Editing Market, By End User– Revenue and Forecast to 2030 (USD Million)
Table 17. France: Gene Editing Market, By Technology – Revenue and Forecast to 2030 (USD Million)
Table 18. France: Gene Editing Market, By Products and Services – Revenue and Forecast to 2030 (USD Million)
Table 19. France: Gene Editing Market, By Application– Revenue and Forecast to 2030 (USD Million)
Table 20. France: Gene Editing Market, By End User– Revenue and Forecast to 2030 (USD Million)
Table 21. Italy: Gene Editing Market, By Technology – Revenue and Forecast to 2030 (USD Million)
Table 22. Italy: Gene Editing Market, By Products and Services – Revenue and Forecast to 2030 (USD Million)
Table 23. Italy: Gene Editing Market, By Application– Revenue and Forecast to 2030 (USD Million)
Table 24. Italy: Gene Editing Market, By End User– Revenue and Forecast to 2030 (USD Million)
Table 25. Spain: Gene Editing Market, By Technology – Revenue and Forecast to 2030 (USD Million)
Table 26. Spain: Gene Editing Market, By Products and Services – Revenue and Forecast to 2030 (USD Million)
Table 27. Spain: Gene Editing Market, By Application– Revenue and Forecast to 2030 (USD Million)
Table 28. Spain: Gene Editing Market, By End User– Revenue and Forecast to 2030 (USD Million)
Table 29. Rest of Europe: Gene Editing Market, By Technology – Revenue and Forecast to 2030 (USD Million)
Table 30. Rest of Europe: Gene Editing Market, By Products and Services – Revenue and Forecast to 2030 (USD Million)
Table 31. Rest of Europe: Gene Editing Market, By Application– Revenue and Forecast to 2030 (USD Million)
Table 32. Rest of Europe: Gene Editing Market, By End User– Revenue and Forecast to 2030 (USD Million)
Table 33. Recent Organic Growth Strategies in US and Europe Gene Editing Market
Table 34. Recent Inorganic Growth Strategies in the US and Europe Gene Editing Market
Table 35. Glossary of Terms, Gene Editing Market
LIST OF FIGURES
Figure 1. Gene Editing Market Segmentation
Figure 2. Gene Editing Market Segmentation, by Region
Figure 3. US and Europe Gene Editing Market Overview
Figure 4. CRISPR Segment Held Largest Share of Gene Editing Market
Figure 5. UK to Show Significant Growth During Forecast Period
Figure 6. US and Europe Gene Editing Market – Leading Country Markets (US$ Million)
Figure 7. US and Europe Gene Editing Market, Industry Landscape
Figure 8. US PEST Analysis
Figure 9. Europe PEST Analysis
Figure 10. Gene Editing Market – Key Industry Dynamics
Figure 11. Gene Editing Market Impact Analysis of Drivers and Restraints
Figure 12. US and Europe Gene Editing Market – Revenue Forecast and Analysis – 2020–2030
Figure 13. Market Positioning of Key Players in US and Europe Gene Editing Market
Figure 14. US and Europe Gene Editing Market, By Technology 2022 & 2030 (%)
Figure 15. US and Europe Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Market Revenue and Forecasts to 2030 (US$ Million)
Figure 16. US and Europe TALEN Market Revenue and Forecasts to 2030 (US$ Million)
Figure 17. US and Europe Antisense Market Revenue and Forecasts to 2030 (US$ Million)
Figure 18. US and Europe Zinc Finger Nucleases (ZFNs) Market Revenue and Forecasts to 2030 (US$ Million)
Figure 19. US and Europe Others Market Revenue and Forecasts to 2030 (US$ Million)
Figure 20. US and Europe Gene Editing Market, By Products and Services 2022 & 2030 (%)
Figure 21. US and Europe Reagents and Consumables Market Revenue and Forecasts to 2030 (US$ Million)
Figure 22. US and Europe Instruments Market Revenue and Forecasts to 2030 (US$ Million)
Figure 23. US and Europe Others Market Revenue and Forecasts to 2030 (US$ Million)
Figure 24. US and Europe Gene Editing Market, By Application 2022 & 2030 (%)
Figure 25. US and Europe Cell Line Engineering Market Revenue and Forecasts to 2030 (US$ Million)
Figure 26. US and Europe Genetic Engineering Market Revenue and Forecasts to 2030 (US$ Million)
Figure 27. US and Europe Diagnostic Application Market Revenue and Forecasts to 2030 (US$ Million)
Figure 28. US and Europe Drug Discovery Market Revenue and Forecasts to 2030 (US$ Million)
Figure 29. US and Europe Others Market Revenue and Forecasts to 2030 (US$ Million)
Figure 30. US and Europe Gene Editing Market, By End User 2022 & 2030 (%)
Figure 31. US and Europe Pharmaceutical & Biotechnology Companies Market Revenue and Forecasts to 2030 (US$ Million)
Figure 32. US and Europe Academic and Research Institutes Market Revenue and Forecasts to 2030 (US$ Million)
Figure 33. US and Europe Contract Research Organization (CROs) Market Revenue and Forecasts to 2030 (US$ Million)
Figure 34. US and Europe Others Market Revenue and Forecasts to 2030 (US$ Million)
Figure 35. US Gene Editing Market– Revenue Forecast and Analysis – 2020- 2030
Figure 36. Europe Gene Editing Market– Revenue Forecast and Analysis – 2020- 2030
Figure 37. Europe: Gene Editing Market -Revenue and Forecasts to 2030, By Country (%)
Figure 38. Germany: Gene Editing Market – Revenue and Forecast to 2030 (USD Million)
Figure 39. UK: Gene Editing Market – Revenue and Forecast to 2030 (USD Million)
Figure 40. France: Gene Editing Market – Revenue and Forecast to 2030 (USD Million)
Figure 41. Italy: Gene Editing Market – Revenue and Forecast to 2030 (USD Million)
Figure 42. Spain: Gene Editing Market – Revenue and Forecast to 2030 (USD Million)
Figure 43. Rest of Europe: Gene Editing Market – Revenue and Forecast to 2030 (USD Million)
Figure 44. Growth Strategies in US and Europe Gene Editing Market
Figure 1. Gene Editing Market Segmentation
Figure 2. Gene Editing Market Segmentation, by Region
Figure 3. US and Europe Gene Editing Market Overview
Figure 4. CRISPR Segment Held Largest Share of Gene Editing Market
Figure 5. UK to Show Significant Growth During Forecast Period
Figure 6. US and Europe Gene Editing Market – Leading Country Markets (US$ Million)
Figure 7. US and Europe Gene Editing Market, Industry Landscape
Figure 8. US PEST Analysis
Figure 9. Europe PEST Analysis
Figure 10. Gene Editing Market – Key Industry Dynamics
Figure 11. Gene Editing Market Impact Analysis of Drivers and Restraints
Figure 12. US and Europe Gene Editing Market – Revenue Forecast and Analysis – 2020–2030
Figure 13. Market Positioning of Key Players in US and Europe Gene Editing Market
Figure 14. US and Europe Gene Editing Market, By Technology 2022 & 2030 (%)
Figure 15. US and Europe Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Market Revenue and Forecasts to 2030 (US$ Million)
Figure 16. US and Europe TALEN Market Revenue and Forecasts to 2030 (US$ Million)
Figure 17. US and Europe Antisense Market Revenue and Forecasts to 2030 (US$ Million)
Figure 18. US and Europe Zinc Finger Nucleases (ZFNs) Market Revenue and Forecasts to 2030 (US$ Million)
Figure 19. US and Europe Others Market Revenue and Forecasts to 2030 (US$ Million)
Figure 20. US and Europe Gene Editing Market, By Products and Services 2022 & 2030 (%)
Figure 21. US and Europe Reagents and Consumables Market Revenue and Forecasts to 2030 (US$ Million)
Figure 22. US and Europe Instruments Market Revenue and Forecasts to 2030 (US$ Million)
Figure 23. US and Europe Others Market Revenue and Forecasts to 2030 (US$ Million)
Figure 24. US and Europe Gene Editing Market, By Application 2022 & 2030 (%)
Figure 25. US and Europe Cell Line Engineering Market Revenue and Forecasts to 2030 (US$ Million)
Figure 26. US and Europe Genetic Engineering Market Revenue and Forecasts to 2030 (US$ Million)
Figure 27. US and Europe Diagnostic Application Market Revenue and Forecasts to 2030 (US$ Million)
Figure 28. US and Europe Drug Discovery Market Revenue and Forecasts to 2030 (US$ Million)
Figure 29. US and Europe Others Market Revenue and Forecasts to 2030 (US$ Million)
Figure 30. US and Europe Gene Editing Market, By End User 2022 & 2030 (%)
Figure 31. US and Europe Pharmaceutical & Biotechnology Companies Market Revenue and Forecasts to 2030 (US$ Million)
Figure 32. US and Europe Academic and Research Institutes Market Revenue and Forecasts to 2030 (US$ Million)
Figure 33. US and Europe Contract Research Organization (CROs) Market Revenue and Forecasts to 2030 (US$ Million)
Figure 34. US and Europe Others Market Revenue and Forecasts to 2030 (US$ Million)
Figure 35. US Gene Editing Market– Revenue Forecast and Analysis – 2020- 2030
Figure 36. Europe Gene Editing Market– Revenue Forecast and Analysis – 2020- 2030
Figure 37. Europe: Gene Editing Market -Revenue and Forecasts to 2030, By Country (%)
Figure 38. Germany: Gene Editing Market – Revenue and Forecast to 2030 (USD Million)
Figure 39. UK: Gene Editing Market – Revenue and Forecast to 2030 (USD Million)
Figure 40. France: Gene Editing Market – Revenue and Forecast to 2030 (USD Million)
Figure 41. Italy: Gene Editing Market – Revenue and Forecast to 2030 (USD Million)
Figure 42. Spain: Gene Editing Market – Revenue and Forecast to 2030 (USD Million)
Figure 43. Rest of Europe: Gene Editing Market – Revenue and Forecast to 2030 (USD Million)
Figure 44. Growth Strategies in US and Europe Gene Editing Market
